Kotak Institutional Equities has initiated coverage on Dr Agarwal's Health Care, India's largest eye care hospital chain, with an 'ADD' rating. The firm has assigned a fair value of Rs 425 per ...

Kotak Institutional Equities initiated coverage on Dr Agarwal's Health Care with an 'Add' rating and Rs 425 target, citing ...

While glaucoma prevalence is growing, glaucoma specialists are in short supply, and accessibility to specialized centers is ...

Ophthalmologists reflect on the transformative impact of COVID-19, highlighting adaptations in patient care, safety protocols ...

Bills in the Minnesota House and Senate would give permission to optometrists to administer injections directly into the eye, ...

Dr. Anurag Agrawal of Ashoka University highlights the need to reform incentives, support early innovation, and align academia with industry. From genomics to AI-driven health tools, the goal is ...

In honor of Ophthalmology Times’ 50th anniversary, we asked a panel of leading ophthalmologists and optometrists across subspecialties to reflect on the most transformative innovations in the field ...

Local patients seeking laser-assisted cataract surgery will no longer have to commute down south to Colorado after the first ...

Gill, MD, discusses faricimab for the management ... After more than 25 years of practicing ophthalmology, I am now exploring the critical intersection of climate change and health and a full ...

Fear of vision loss may deter some patients from undergoing necessary cataract surgery, according to a newly published study.

Kotak Institutional Equities has initiated coverage on Dr. Agarwal’s Eye Hospitals with an ‘add’ rating and a fair value of Rs 425, implying a 5% upside from the current market price. The brokerage ...